Medizinische Fakultät

Factors Associated With Persisting Olfactory Dysfunction After COVID-19 (2025) Prem B, Liu DT, Boehme K, Maurer MT, Renner B, Mueller CA Journal article The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. (2025) Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, Klümper N Journal article Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy - A multicenter study on 2419 patients from the prospective skin cancer registry ADOReg. (2025) Kött J, Zell T, Zimmermann N, Rünger A, Smit DJ, Abeck F, Geidel G, et al. Journal article Clinical Pharmacist Counselling Improves Long-term Medication Safety and Patient-reported Outcomes in Anti-TNF-treated Patients With Inflammatory Bowel Diseases: The Prospective, Randomized AdPhaNCED Trial. (2025) Plechschmidt J, Fietkau K, Hepp T, Dietrich P, Fischer S, Krebs S, Neurath M, et al. Journal article Only IF/TA in the Histological Evaluation of Post-Reperfusion Baseline Biopsies Correlates With Kidney Transplant Outcome. (2025) Bachmann Q, Torrez C, Büttner-Herold M, Haller B, Haberfellner F, Hausinger R, Assfalg V, et al. Journal article Empowering personalized oncology: evolution of digital support and visualization tools for molecular tumor boards. (2025) Strantz C, Böhm D, Ganslandt T, Börries M, Metzger P, Pauli T, Blaumeiser A, et al. Journal article Long-term stability of sufentanil quantified by UPLC-MS-MS in human plasma frozen for 11 years at -20°C. (2025) Wehrfritz A, Schmidt S, Ihmsen H, Schüttler J, Jeleazcov C Journal article Tumor budding and lymphovascular invasion as prognostic factors in p16-positive oropharyngeal squamous cell carcinomas. (2025) Stögbauer F, Wirth M, Lauterbach M, Wollenberg B, Schmidl B, Hoch CC, Ourailidis I, et al. Journal article A comparison of real-world data on adjuvant treatment in patients with stage III BRAF V600 mutated melanoma - Results of systematic literature research. (2025) Amaral T, Nanz L, Higuita LMS, Ascierto P, Berking C, Couselo EM, Donia M, et al. Journal article Venetoclax-based salvage therapy as a bridge to transplant is feasible and effective in patients with relapsed/refractory AML. (2025) Unglaub JM, Schlenk RF, Middeke JM, Krause S, Kraus S, Einsele H, Kramer M, et al. Journal article